III. eranskina PKGaren aukeraketa, AGREE tresnan oinarrituta

Similar documents
Long-Term Care Updates

Supplementary Online Content

Hypertension Treatment and Control in Older Adult at Tanjung Sari Public Health Center

New Clinical Trends in Geriatric Medicine. April 8, 2016 Amanda Lathia, MD, MPhil Staff, Center for Geriatric Medicine


Disclosure. Objectives. Which Target to Target? A Blood Pressure Goal Update

The recommendations for the management of

IMPACT OF PILL BURDEN AND SOCIO-ECONOMIC STATUS OF PATIENTS ON ADHERENCE TO PHARMACOLOGIC THERAPY IN ELDERLY

2017 High Blood Pressure Clinical Practice Guideline

The debate about appropriate blood pressure

Efficacy and Safety of a Single-Pill Fixed-Dose Combination of Azilsartan and Amlodipine

Current strategies for managing hypertension

Methods. Study design

The older patient with hypertension: care and cure

Instructions Read out the case authors and their disclosure information.

Comparison of the Microlife A2 Basic (BP3GQ1-3P) with the Microlife BP3BT0-A and Microlife BP A100 Plus

Disclosures. Hypertension: Nationwide Dilemma. Learning Objectives. What s Currently Recommended? Specific Concerns 3/9/2012

Combination therapy with losartan/ hydrochlorothiazide for blood pressure reduction and goal attainment in a real-world clinical setting in Japan

Comparison of the Microlife A6 PC (BP3GU1-8Y) with the Microlife BP3BT0-A and Microlife BP A100 Plus

Developing Hypertension Guidelines: An Evolving Process

Keywords: Visit-to-visit variability; Seasonal variation; Blood pressure. Introduction

How clinically important are the results of the large trials in hypertension?

Target Blood Pressure in Patients with Diabetes: Asian Perspective

Abstract. Introduction. Volume 54 Number 1 Jan.-March, Philippine Journal of Internal Medicine. Clinical Trial

Should beta blockers remain first-line drugs for hypertension?

The Open Hypertension Journal, 2015, 7, 1-6 1

Protocol. Automated Ambulatory Blood Pressure Monitoring for the Diagnosis of Hypertension in Patients with Elevated Office Blood Pressure

Hypertension Management: Making Sense of Guidelines and Therapy Options for the Elderly

Improving the Outcomes of

More than 60 % patients of chronic kidney diseases (CKD) have hypertension. Control of blood pressure (BP) in CKD subjects is an important strategy

Aortic Root Dilatation as a Marker of Subclinical Left Ventricular Diastolic Dysfunction in Patients with Cardiovascular Risk Factors

Effectiveness of combination therapy with nifedipine GITS: a prospective, 12-week observational study (AdADOSE)

Nursing Faculty Research Publications

Candesartan Antihypertensive Survival Evaluation in Japan (CASE-J) Trial of Cardiovascular Events in High-Risk Hypertensive Patients

MedStar Health considers External Counterpulsation Therapy (ECP) medically necessary for the following indications:

Screening for Cardiovascular Risk (2/6/09)

EXPERT CONSENSUS DOCUMENT. Wilbert S. Aronow, MD, FACC, Co-Chair* Jerome L. Fleg, MD, FACC, Co-Chair Carl J. Pepine, MD, MACC, Co-Chair*

Essential Hypertension Management Considerations By Elaine Lewis, ND

Qué factores de riesgo lipídicos debemos controlar? En qué medida?

MEDICAL POLICY SUBJECT: AUTOMATED AMBULATORY BLOOD PRESSURE MONITORING

Therapeutic Advances in Cardiovascular Disease

A Study of cardiovascular risk factors correlation with the angiographic severity of coronary artery disease using Syntax score

Dr.Kamal Waheeb AlGhalayini MD, SCC Med. MSc-Card Associate professor, Consultant Cardiology. Head non-invasive lab. Vice dean for clinical affaires

Knowledge and Implementation of the New European Guide in the Management of Arterial Hypertension. The Cigema Survey

TITLE: Cardiac Troponin for the Diagnosis of Acute Coronary Syndrome in the Emergency Department: A Review of Guidelines

Until the 2017 ACC/AHA hypertension guidelines1

Chapman University Digital Commons. Chapman University. Michael S. Kelly Chapman University,

Curriculum Vitae. Professor Juan Carlos Kaski, DSc, DM (Hons), MD, FRCP, FESC,FAHA, FRSM. Present Position and Address. Training and Education

Measurement of Arterial Stiffness: Why should I measure both PWA and PWV?

International Symposium on: URIC ACID AND CARDIOMETABOLIC DISEASE: FROM BENCH TO BEDSIDE

C. Michael Wright, MD FACC DABCL_FNLA Biography March 2017

Blood Pressure Targets: Where are We Now?

Heart Failure. Disclosures. Objectives: 8/28/2017. This is not a virus. It doesn t go away. none

JNC 8 -Controversies. Sagren Naidoo Nephrologist CMJAH

Mitral Valve Reference Center. Ariana González Gómez Heart Valve Clinic. University Hospital Ramón y Cajal. Madrid. Spain.

Int. J. Pharm. Sci. Rev. Res., 36(1), January February 2016; Article No. 06, Pages: JNC 8 versus JNC 7 Understanding the Evidences

Information contained in this listing is collected and maintained by the American Board of Internal Medicine.

Do Clinical Practice Guidelines Improve Outcomes?

Effectiveness of Add-On Low-Dose Diuretics in Combination Therapy for Hypertension: Losartan/Hydrochlorothiazide vs. Candesartan/Amlodipine

Chapter 7: Blood pressure management in elderly persons with CKD ND Kidney International Supplements (2012) 2, ; doi: /kisup.2012.

Outcomes and Perspectives of Single-Pill Combination Therapy for the modern management of hypertension

Adherence to Antihypertensive Medication in the older hypertensive patients: the role of blood pressure measurement assistance

American College of Cardiology Foundation

Abnormality of risk factors for atherosclerotic disease among young Japanese aged years old: an evaluation of health checkup data

Conflicts of Interest. Hypertension Guidelines Have Your Blood Pressure Up? Learning Objectives-Technician. Learning Objectives-Pharmacist

Corporate Medical Policy

The Rise and Fall of Hypertension: Lessons Learned from Eastern Europe

Click to edit Master title style

Which antihypertensives are more effective in reducing diastolic hypertension versus systolic hypertension? May 24, 2017

Detection of Atrial Fibrillation Using a Modified Microlife Blood Pressure Monitor

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE

Achieving Cholesterol Management Goals: Identifying Clinician-Centered Challenges to Optimal Patient Care

Clinical Guidelines appraised with the AGREE instrument

Clinical Policy Title: Ambulatory blood pressure monitoring

Cardiovascular Risk Assessment: A Systematic Review of Guidelines.

The Effects of Aquarobics on Blood Pressure, Heart Rate, and Lipid Profile in Older Women with Hypertension

What s In the New Hypertension Guidelines?

Effect of renal denervation on glucose metabolism after a 12 month follow-up

Strokes After TAVR: Perspectives from the US CoreValve Trials

Symptoms associated with an abnormal echocardiogram in elderly primary care hypertension patients

622 KARIO K et al. Safety and Efficacy of Renal Denervation at 3 Years

, 13TH EUGMS CONGRESS NICE GOALS OF ANTIHYPERTENSIVE TREATMENT IN THE FRAIL IS SPRINT APPLICABLE? CONTRA

Secondary cardiovascular prevention in older adults: an evidence based review

State of the art treatment of hypertension: established and new drugs. Prof. M. Burnier Service of Nephrology and Hypertension Lausanne, Switzerland

Association of Serum Uric Acid With Blood Pressure in Japanese Men

POST-M.D. TRAINEES EXITING ALBERTA TRAINING PROGRAMS IN JULY, 2015 AT THE COMPLETION OF POST-M.D

Effects of Calcium Antagonists on Insulin Release

Strategies to Reduce Premature Cardiovascular Morbidity and Mortality

American Journal of Human Genetics. American Journal of Hypertension. American Journal of Neuroradiology

Summary Transcatheter aortic valve implantation: Evaluation of the evidence and synthesis of organizational issues

Statins in the elderly : Is there a rationale?

Geographic Location, Field of Post-M.D. Training

ORIGINAL ARTICLE Questionnaire-based study of cerebrovascular complications during pregnancy in Aichi Prefecture, Japan

The JNC 8 Guidelines: A Clinical Review

Natriuretic Peptides The Cardiologists View. Christopher defilippi, MD University of Maryland Baltimore, MD, USA

Significance of the second peak of systolic blood pressure for identifying both high and low cardiovascular risk states

TABLE D-1 POST-M.D. TRAINEES EXITING QUEBEC TRAINING PROGRAMS IN JULY, 2014 AT THE COMPLETION OF POST-M.D. TRAINING

Hypertension and frailty in older adults

Beta-Blockers In Clinical Practice By J. M. Cruickshank READ ONLINE

Prevalence of type 2 diabetes mellitus in elderly in a primary care facility: An ideal facility

Transcription:

III. eranskina PKGaren aukerak, AGREE tresnan oinarrituta HTAri buruzko PKGa 120 100 80 60 40 20 0 Indepedencia Calidad Global Nice- Canadiens-2012 ICSI*- Japon- Europea- ACCF*- Nice Kanadarra 2012 ICSI* Japonia Europarra ACCF* Irismena helburua Inplikatutakoen parte-hartzea Zorroztasuna egitean Argitasuna aurkezpena Aplikagarritasuna Argitalpenindependentzia Kalitate orokorra 100 92 99 100 100 100 100 67 56 73 86 38 75 75 53 42 23 50 56 6 46 0 19 0 53 2 0 28 36 28 5 8 0 0 28 89 39 54 61 17 75 75 -Australiarra: 2010 National Heart Foundation of Australia (National Blood Pressure and Vascular Disease Advisory Committee).Guide to management of hypertension 2008. Updated December 2010. Eskuragarri hemen: www.heartfoundation.org.au -Nice NICE clinical guideline 127. Hypertension Clinical management of primary hypertension in adults. National Institute for Health and Clinical Excellence. London.. Eskuragarri hemen: www.nice.org.uk -US Preventive Task Force 2007 (bahek bakarrik)

Screening for high blood pressure: U.S. Preventive Services Task Force reaffirmation recommendation statement. Ann Intern Med 2007;147(11):783-6. -Europarra Mancia G, Laurent S, Agabiti-Rosei E, Ambrosioni E, Burnier M, Caulfield MJ, et al. Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. J Hypertens ;27(11):2121-58. -Japoniarra Ogihara T, Kikuchi K, Matsuoka H, Fujita T, Higaki J, Horiuchi M, et al. The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH ). Hypertens Res ;32(1):3-107. -Kanadarra -2012 Rabi DM, Daskalopoulou SS, Padwal RS, Khan NA, Grover SA, Hackam DG, et al. The Canadian Hypertension Education Program recommendations for the management of hypertension: blood pressure measurement, diagnosis, assessment of risk, and therapy. Can J Cardiol ;27(4):415-33 e1-2. Y su versión web del 2012 http://www.hypertension.ca/ -Amerikarra. Edadetua () Aronow WS, Fleg JL, Pepine CJ, Artinian NT, Bakris G, Brown AS, et al. ACCF/AHA expert consensus document on hypertension in the elderly: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus documents developed in collaboration with the American Academy of Neurology, American Geriatrics Society, American Society for Preventive Cardiology, American Society of Hypertension, American Society of Nephrology, Association of Black Cardiologists, and European Society of Hypertension. J Am Coll Cardiol ;57(20):2037-114 -ICSI 2010 Institute for Clinical Systems Improvement. Hypertension Diagnosis and Treatment Thirteenth Edition November 2010. Eskuragarri hemen: www.icsi.org Aukeratutakoak: NICE Kanadarra

Diabetesari buruzko PKGa 120% 100% 80% 60% 40% 20% 0% Dominio 1. Dominio 2. Dominio 3. Dominio 4. Presentación GPC-NZ GPC NICE GPC SIGN GPC AUSTRAL Dominio 5. Dominio 6. Independencia Dominio 1. objetivo 1. eremua Dominio 2. de implicados 2. eremua Dominio 3. 3. eremua Dominio 4. 4. eremua Dominio 5. 5. eremua Dominio 6. Independencia 6. eremua Irismena helburua Inplikatutakoen parte-hartzea Zorroztasuna egitean Argitasuna aurkezpena Aplikagarritasuna Argitalpenindependentzia GPC-NZ GPC NICE GPC SIGN GPC AUSTRAL NZ PKG NICE PKG SIGN PKG PKG AUSTRALIARRA

Anexo I-Selección GPC en base al instrumento AGREE GPC sobre HTA 120 100 80 60 40 20 0 Indepedencia Calidad Global Nice- Canadiens-2012 ICSI*- Japon- Europea- ACCF*- Nice Canadiense 2012 ICSI* Japón Europea ACCF* Indepedencia editorial Calidad Global 100 92 99 100 100 100 100 67 56 73 86 38 75 75 53 42 23 50 56 6 46 0 19 0 53 2 0 28 36 28 5 8 0 0 28 89 39 54 61 17 75 75 -Australiana: 2010 National Heart Foundation of Australia (National Blood Pressure and Vascular Disease Advisory Committee).Guide to management of hypertension 2008. Updated December 2010.Disponible en www.heartfoundation.org.au -Nice NICE clinical guideline 127. Hypertension Clinical management of primary hypertension in adults. National Institute for Health and Clinical Excellence.London. Disponible en www.nice.org.uk -US Preventive Task Force 2007 (sólo cribado)

Screening for high blood pressure: U.S. Preventive Services Task Force reaffirmation recommendation statement. Ann Intern Med 2007;147(11):783-6. -Europea Mancia G, Laurent S, Agabiti-Rosei E, Ambrosioni E, Burnier M, Caulfield MJ, et al. Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. J Hypertens ;27(11):2121-58. -Japonesa Ogihara T, Kikuchi K, Matsuoka H, Fujita T, Higaki J, Horiuchi M, et al. The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH ). Hypertens Res ;32(1):3-107. -Canadiense -2012 Rabi DM, Daskalopoulou SS, Padwal RS, Khan NA, Grover SA, Hackam DG, et al. The Canadian Hypertension Education Program recommendations for the management of hypertension: blood pressure measurement, diagnosis, assessment of risk, and therapy. Can J Cardiol ;27(4):415-33 e1-2. Y su versión web del 2012 http://www.hypertension.ca/ -Americana Anciano () Aronow WS, Fleg JL, Pepine CJ, Artinian NT, Bakris G, Brown AS, et al. ACCF/AHA expert consensus document on hypertension in the elderly: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus documents developed in collaboration with the American Academy of Neurology, American Geriatrics Society, American Society for Preventive Cardiology, American Society of Hypertension, American Society of Nephrology, Association of Black Cardiologists, and European Society of Hypertension. J Am Coll Cardiol ;57(20):2037-114 -ICSI 2010 Institute for Clinical Systems Improvement. Hypertension Diagnosis and Treatment Thirteenth Edition November 2010.Disponible en www.icsi.org Seleccionadas: NICE y Canadiense

GPC sobre Diabetes 120% 100% 80% 60% 40% 20% 0% Dominio 1. Dominio 2. Dominio 3. Dominio 4. Presentación GPC-NZ GPC NICE GPC SIGN GPC AUSTRAL Dominio 5. Dominio 6. Independencia